iCare, founded in 2003 and headquartered in Finland, stands as a forefront innovator in the Biotechnology and Health Care industries. Known for their slogan, "Establishing the next level of eye care," they are renowned for providing advanced ophthalmic management solutions through a comprehensive lineup of medical devices.
Their offerings include retinal imaging, fundus perimeters, and rebound tonometers, complemented by software solutions that enhance operational efficiency and care continuity. Notably, their TrueColor Confocal technology and automated platforms streamline diagnostics, while the proprietary rebound tonometry enables home use with remarkable ease and accuracy.
Part of the Revenio Group with global entities like Icare Finland Oy and Icare USA, Inc., the company is positioned as a leader in ocular disease management. While it has yet to report any recent investments, iCare remains committed to redefining ophthalmic care, aiming for accessibility and reliability for both clinics and patients.